Pure Global AI
NCT06325891Recruiting

Microbiota in Gastric Cancer by Gastric Mucosal Brushing

Microbiota Diversity and Composition in Gastric Cancer by Gastric Mucosal Brushing: a Cross-sectional Case-control Study
King Chulalongkorn Memorial HospitalClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Gastric Cancer
Drug/Device/Intervention
Gastric mucosal brushing
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
King Chulalongkorn Memorial Hospital
Location
Bangkok,Bangkok, Thailand
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2024
End date
May 31, 2025
Enrollment
40 participants
Primary outcome

Microbiome analysis using gastric mucosal brushing

Summary

Many studies have shown a significant change of diversity and composition in gut microbiota
 across the gastric carcinogenesis process, particularly in patients with gastric cancer.
 However, there has been no analysis of gastric microbiota using the mucosal brushing
 technique, despite its favoring benefit in microbiota study. Therefore, this study aims to
 evaluate microbiota profile in patients with gastric cancer, compared to those without
 gastric cancer by using mucosal brush sampling. This will improve current knowledge of the
 potential role of the microbiome in patient gastric cancer as a future biomarker marker using
 brushing sampling.

ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06325891
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06325891 through Pure Global AI's free database. This phase not specified trial is sponsored by King Chulalongkorn Memorial Hospital and is currently Recruiting. The study focuses on Gastric Cancer. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.